Pfizer Secures Vyndamax Patent Till 2031, Settles Disputes with Cipla, Hikma, Dexcel Pharma Written By sheeba farhat29 April 2026 3:44 PM ISTBengaluru: Pfizer said on Tuesday it has settled patent disputes with three generic drugmakers over its blockbuster heart drug Vyndamax, effectively...
Pfizer Enters China's GLP-1 Market with Xianweiying Pre-Orders, Intensifies Weight-Loss Drug Race Written By sheeba farhat26 April 2026 9:30 AM ISTNew Delhi: Pfizer's GLP-1 weight management treatment Xianweiying is available for pre-order in China, a Reuters check on a local e-commerce...
Pfizer Strategy Shake-Up: Andrew Baum to Exit After Transitioning to Advisor Role Written By sheeba farhat21 April 2026 10:55 PM ISTNew Delhi: Pfizer's Chief Strategy and Innovation Officer, Andrew Baum, is transitioning to a new role and will eventually leave the company as part...
COVID Vaccine Trial Setback: Pfizer, BioNTech Halt Study Over Low Enrollment Written By sheeba farhat3 April 2026 2:57 PM ISTLondon: Vaccine makers Pfizer and BioNTech have halted recruitment for a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged...
Experimental Lyme Vaccine Shows Promising Protection in Phase 3 trial Written By Dr. Kamal Kant Kohli28 March 2026 11:00 AM ISTAn experimental six-strain Lyme disease vaccine developed by Pfizer has shown over 70% efficacy in individuals aged 5 years and older. In a phase 3...
Pfizer, Valneva Lyme Disease Vaccine Shows Over 70% Efficacy in Late-Stage Trial Written By sheeba farhat25 March 2026 11:08 PM ISTBengaluru: The U.S. drugmaker Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a...
Pfizer, Teva Fail to Disqualify Former Prosecutor in US Generic Drug Price-Fixing Case Written By sheeba farhat13 March 2026 10:15 PM ISTWashington: Pfizer, Teva and other major drugmakers have failed to persuade a federal judge to disqualify a former prosecutor who is representing...
Pfizer's GLP-1 Drug Xianweiying Wins China Approval for Long-Term Weight Management Written By sheeba farhat8 March 2026 11:30 AM ISTShanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said...
Pfizer CEO Flags Concerns Over USFDA Biologics Chief, Cites Vaccine Policy Uncertainty Written By sheeba farhat3 March 2026 8:52 PM ISTBengaluru: Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay...
BioNTech Sues Moderna Over mNEXSPIKE, Alleges Patent Infringement Linked to Comirnaty Technology Written By sheeba farhat22 Feb 2026 2:00 PM ISTNew Delhi: German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's COVID-19 vaccine...
Pfizer Awards Rs 60 Lakh Each to 14 Healthtech Startups Under INDovation 2025 Written By sheeba farhat14 Feb 2026 10:30 AM ISTNew Delhi: Pfizer has announced the winners of the INDovation Program 2025, selecting 14 healthtech startups that will each receive grants of Rs 60...
Once-Monthly GLP-1 Injection Shows Significant Weight Loss Without Plateau in non diabetics in Phase 2 trial Written By Dr. Kamal Kant Kohli13 Feb 2026 8:00 AM ISTPfizer reported that its ultra-long-acting, once-monthly GLP-1 injectable achieved up to 12.3% placebo-adjusted weight loss by week 28, with no...
